1mg semaglutide Injection at ₹ 15000/piece | Semaglutide Injection in Nagpur and a shorter life Administration | Ozempic® (semaglutide) injection

Several companies, like Regeneron, are working on muscle-sparing (or even gaining) drugs to pair up with GLP-1s

Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist with similar effects

September 2025: Pfizer announced its agreement to acquire Metsera in a deal valued at up to USD 7.3 billion, strengthening its pipeline of next-generation GLP-1, amylin, and obesity therapies

Everyone deserves access to effective weight loss treatments

Clinical trials of GLP-1 anti-diabetic and anti-obesity medications have reported varied adverse drug reactions (ADRs)

The Asia Pacific Region, including China & India, is growing rapidly because of increasing populations of diabetic patients and those that are obese, better access to healthcare, and the growing awareness of available weight management therapies